Beryl Drugs Limited (BOM:524606)
India · Delayed Price · Currency is INR 19.85
+0.82 (4.31%)
At close: May 27, 2026
Beryl Drugs Market Cap
Beryl Drugs has a market cap or net worth of 100.67 million as of May 27, 2026. Its market cap has decreased by -10.59% in one year.
Market Cap
100.67M
Enterprise Value
143.02M
Revenue
176.65M
Ranking
n/a
PE Ratio
713.99
Stock Price
19.85
Market Cap Chart
Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 100.67M, an increase of 2,625.08%. That is a compound annual growth rate of 17.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 96.51M | -18.68% |
| Dec 31, 2025 | 118.68M | -35.27% |
| Dec 31, 2024 | 183.34M | 63.50% |
| Dec 29, 2023 | 112.14M | 70.08% |
| Dec 30, 2022 | 65.93M | 7.26% |
| Dec 31, 2021 | 61.47M | 54.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Norris Medicines | 141.91M |
| Parmax Pharma | 141.80M |
| Emmessar Biotech & Nutrition | 130.90M |
| Colinz Laboratories | 122.20M |
| Shamrock Industrial Company | 121.74M |
| Ortin Global | 111.81M |
| Unjha Formulations | 86.29M |
| Decipher Labs | 73.73M |